In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics (ASX:LDX) has signed an exclusive…
One of the punching bags of the ASX, Lumos Diagnostics (ASX: LDX), which develops diagnostics for healthcare professionals to more…
While small cap shareholders have become accustomed to major share price gains once a medtech or biotech receives FDA approval…
Rapid antigen tests (or lack thereof) have dominated the headlines for months now. Turning your kitchen counter into a mini…
With 'Rapid Antigen Test' having only taken several days to likely be one of the most commonly used words of…
Having secured approval from regulators in Canada last month, Lumos Diagnostics (ASX: LDX) is set to dispatch the first orders…